JMH
J.M. Hartwell Portfolio holdings
AUM
$560M
This Quarter Return
+0.55%
1 Year Return
+7.81%
3 Year Return
+73.28%
5 Year Return
+120.37%
10 Year Return
–
AUM
$438M
AUM Growth
+$438M
(-6.5%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
65.43%
Holding
117
New
9
Increased
19
Reduced
43
Closed
14
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$8.54M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$4.62M |
| 3 |
Palo Alto Networks
PANW
|
$3.53M |
| 4 |
AGN
Allergan plc
AGN
|
$2.61M |
| 5 |
Home Depot
HD
|
$2.35M |
Top Sells
| 1 |
Community Health Systems
CYH
|
$13.6M |
| 2 |
CVS Health
CVS
|
$5.68M |
| 3 |
Lowe's Companies
LOW
|
$5.47M |
| 4 |
Walt Disney
DIS
|
$4.52M |
| 5 |
Check Point Software Technologies
CHKP
|
$3.47M |
Sector Composition
| 1 | Technology | 28.27% |
| 2 | Communication Services | 27.25% |
| 3 | Consumer Discretionary | 12.97% |
| 4 | Financials | 12.17% |
| 5 | Healthcare | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Walt Disney
DIS
$213B
| $1.45M | 0.33% |
14,204
-44,200
| -76% | -$4.52M |
|
27
Illumina
ILMN
$15.8B
| $1.43M | 0.33% |
8,105
+475
| +6% | +$83.5K |
|
28
Novartis
NVS
$245B
| $1.3M | 0.3% |
14,153
| – | – |
|
|
NJ
29
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $1.21M | 0.28% |
69,800
-1,000
| -1% | -$17.3K |
|
30
Pure Cycle
PCYO
$243M
| $914K | 0.21% |
184,733
-4,100
| -2% | -$20.3K |
|
|
LUX
31
DELISTED
Luxottica Group
LUX
| $852K | 0.19% |
12,300
-300
| -2% | -$20.8K |
|
32
Blackstone
BX
$134B
| $835K | 0.19% |
26,375
+13,275
| +101% | +$420K |
|
|
SHPG
33
DELISTED
Shire pic
SHPG
| $780K | 0.18% |
3,800
| – | – |
|
|
WBA
34
DELISTED
Walgreens Boots Alliance
WBA
| $773K | 0.18% |
+9,300
| New | +$773K |
|
35
Toyota
TM
$254B
| $727K | 0.17% |
6,200
-400
| -6% | -$46.9K |
|
36
Thermo Fisher Scientific
TMO
$186B
| $724K | 0.17% |
5,920
+1,675
| +39% | +$205K |
|
|
BAY
37
DELISTED
BAYER AG SPONS ADR
BAY
| $703K | 0.16% |
5,500
| – | – |
|
38
Fresenius Medical Care
FMS
$15.1B
| $690K | 0.16% |
17,700
| – | – |
|
39
Icon
ICLR
$13.8B
| $688K | 0.16% |
9,700
-1,500
| -13% | -$106K |
|
40
Royal Caribbean
RCL
$98.7B
| $677K | 0.15% |
7,600
| – | – |
|
41
Diageo
DEO
$62.1B
| $647K | 0.15% |
6,000
-200
| -3% | -$21.6K |
|
42
Prudential
PUK
$34B
| $645K | 0.15% |
15,300
-300
| -2% | -$12.6K |
|
43
Novo Nordisk
NVO
$251B
| $640K | 0.15% |
11,800
| – | – |
|
44
Procter & Gamble
PG
$368B
| $636K | 0.15% |
8,844
| – | – |
|
|
DT
45
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
| $635K | 0.15% |
35,800
-800
| -2% | -$14.2K |
|
46
NetEase
NTES
$86.2B
| $604K | 0.14% |
5,030
-300
| -6% | -$36K |
|
47
Teva Pharmaceuticals
TEVA
$21.1B
| $587K | 0.13% |
10,390
| – | – |
|
|
SYT
48
DELISTED
Syngenta Ag
SYT
| $568K | 0.13% |
8,900
-200
| -2% | -$12.8K |
|
49
AB InBev
BUD
$122B
| $542K | 0.12% |
5,097
-200
| -4% | -$21.3K |
|
50
Biogen
BIIB
$19.4B
| $525K | 0.12% |
1,800
| – | – |
|